PharmaShots | Incisive News in 3 Shots

Subscribe Now

jasmine

Amgen and Allergan Report Results of ABP 798 (biosimilar- rituximab) in JASMINE Study for Non-Hodgkin's Lymphoma

Amgen and Allergan Report Results of ABP 798 (biosimilar- rituximab) in JASMINE Study for Non-Hodgkin's Lymphoma

August 23, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us